DIAGNOS Inc. (CVE:ADK – Get Free Report)’s stock price traded down 1.5% during mid-day trading on Tuesday . The company traded as low as C$0.33 and last traded at C$0.34. 103,500 shares changed hands during trading, an increase of 14% from the average session volume of 90,800 shares. The stock had previously closed at C$0.34.
Analyst Ratings Changes
Separately, Ventum Cap Mkts raised DIAGNOS to a “strong-buy” rating in a report on Wednesday, July 17th.
Get Our Latest Stock Report on DIAGNOS
DIAGNOS Stock Performance
DIAGNOS (CVE:ADK – Get Free Report) last posted its earnings results on Wednesday, August 21st. The company reported C($0.01) earnings per share for the quarter, beating analysts’ consensus estimates of C($0.02) by C$0.01. The firm had revenue of C$0.04 million during the quarter, compared to the consensus estimate of C$0.07 million. On average, sell-side analysts anticipate that DIAGNOS Inc. will post -0.02 EPS for the current year.
About DIAGNOS
DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes.
Featured Articles
- Five stocks we like better than DIAGNOS
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- Using the MarketBeat Stock Split Calculator
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- Do ETFs Pay Dividends? What You Need to Know
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for DIAGNOS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DIAGNOS and related companies with MarketBeat.com's FREE daily email newsletter.